cogent db

herbal drug produced by Cybele Herbal Laboratories Ltd. Kochi, Kerala State, India - each tablet contains Azadirachta indica (3.0 g), Phyllanthus embilica (0.7 g), Circuma longa (0.8 g), Trigonella foenum graceum linn (0.1 g), Syzygium cumini (2.0 g), Tribulus terrestris (1.0 g), Terminalia bellirica (0.7 g), Terminalla chebula (0.7 g), and Routula aquatica (1.0 g);

Networked: 6 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Pari, L: 3 articles (05/2003 - 01/2002)
2.	Saravanan, G: 3 articles (05/2003 - 01/2002)
3.	Venkateswaran, S: 1 article (11/2002)
4.	Achike, Francis I: 1 article (08/2002)
5.	Hashim, Rohaini: 1 article (08/2002)
6.	Hockaday, T Derek R: 1 article (08/2002)
7.	Kaur, Gurpreet: 1 article (08/2002)
8.	Kumar, Prem: 1 article (08/2002)
9.	Shekhar, K Chandra: 1 article (08/2002)
10.	Khrushcheva, Iu V: 1 article (01/2002)

Related Diseases

1.	Type 2 Diabetes Mellitus (MODY) 08/01/2002 - "These results concur with earlier animal studies that indicate that Cogent db is safe, reliable, tolerable, and efficacious in the control of type 2 diabetes mellitus." 01/01/2002 - "The scheme of investigation of efficacy of food dietary supplements in complex treatment of patients with diabetes mellitus type 2 associated with obesity was offered on basis of study of influence "Cogent DB+" on mechanisms of metabolic disorders in these patients."
2.	Obesity 01/01/2002 - "The scheme of investigation of efficacy of food dietary supplements in complex treatment of patients with diabetes mellitus type 2 associated with obesity was offered on basis of study of influence "Cogent DB+" on mechanisms of metabolic disorders in these patients."
3.	Diabetes Mellitus 05/01/2003 - "Thus our study shows that Cogent db exhibits a strong antihyperlipidaemic effect, which could exert a beneficial action against macrovascular complications (cardiovascular disease) associated with diabetes mellitus." 01/01/2002 - "Antidiabetic effect of Cogent db, a herbal drug in alloxan-induced diabetes mellitus."
4.	Cardiovascular Diseases (Cardiovascular Disease) 05/01/2003 - "Thus our study shows that Cogent db exhibits a strong antihyperlipidaemic effect, which could exert a beneficial action against macrovascular complications (cardiovascular disease) associated with diabetes mellitus."
5.	Body Weight (Weight, Body) 05/01/2003 - "The rats were divided into four groups after the induction of alloxan diabetes: normal rats; diabetic control; diabetic rats given Cogent db (0.45 g/kg body weight); diabetic rats given glibenclamide (600 micro g/kg body weight). " 11/01/2002 - "In the experiment, six rats were used in each group: Group 1, normal rats given 2 ml of saline; Group 2, diabetic control rats given 2 ml of saline; Group 3, diabetic rats given aqueous solution of cogent db (0.45 g/body kg weight); and Group 4, diabetic rats given aqueous solution of glibenclamide (600 micro g/kg body weight). "

Related Drugs and Biologics

1.	Glyburide (Glibenclamide)
2.	Plant Preparations (Preparation, Plant)
3.	Solutions
4.	Hypoglycemic Agents (Hypoglycemics)
5.	Dietary Fiber
6.	Blood Glucose (Blood Sugar)
7.	Alloxan